Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171520-22-000314
Filing Date
2022-05-19
Accepted
2022-05-19 21:59:40
Documents
2
Period of Report
2022-05-13

Document Format Files

Seq Description Document Type Size
1 doc3_1004.html 3  
1 doc3_1004.xml 3 3973
2 POWER OF ATTORNEY ex24.htm EX-24 7253
  Complete submission text file 0001171520-22-000314.txt   12883
Mailing Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075
Business Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075 9499006833
ClearPoint Neuro, Inc. (Issuer) CIK: 0001285550 (see all company filings)

EIN.: 582394628 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 120 S. SIERRA AVENUE SUITE 100 SOLANA BEACH CA 92075
Business Address
STIGALL L. JEREMY (Reporting) CIK: 0001929859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34822 | Film No.: 22945180